Speak up, stay strong, and we can take control of our health - Watch FARE's PSA, "Empower Yourself, Empower Each Other."

FARE - Food Allergy Research & Education Logo

Media Room

In The News

Beckman Coulter Life Sciences has launched a next-generation Basophil Activation Test to support safer allergy research and reduce the need for risky oral food challenge

New Food

About 10% of Americans have a food allergy, but restaurants have not always done a good job of catering to them. A new partnership between allergy nonprofit FARE and tech supplier EveryBite hopes to change that.

Restaurant Business

Beckman Coulter Life Sciences introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively characterise allergies without exposure to potentially harmful allergens.

European Pharmaceutical Manufacturer

Our experts help you spot the sneaky aliases of ingredients that commonly cause reactions.

HealthCentral

Catch up with the latest food service industry news with 5 things with FSD.

Foodservice Director

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities.

Pharma Executive

Media Contact: 

media@foodallergy.org.
 

To download a quick reference guide for food allergy, click here.


About FARE (Food Allergy Research & Education)

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—research, education, and advocacy. FARE's initiatives strive for a future free from food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. To learn more, visit FoodAllergy.org.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.